Literature DB >> 16731153

Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass.

Chung-Hsi Hsing1, Mei-Yi Hsieh, Wei-Yu Chen, Edmund Cheung So, Bor-Chih Cheng, Ming-Shi Chang.   

Abstract

BACKGROUND: Interleukin (IL)-19, IL-20, and IL-22, three novel cytokines in the IL-10 family, have recently been discovered. The biological functions and clinical implications of these cytokines are not clear. We aimed to analyze if serum levels of these cytokines were altered in inflammatory responses of postoperative cardiopulmonary bypass (CPB) and investigate the molecular mechanism involved in cytokine induction.
METHODS: Twenty-five patients undergoing elective aortic-coronary bypass grafting with CPB were enrolled in this study. Blood samples withdrawn at (T1) before anesthesia, (T2) CPB start, (T3) CPB end, (T4) 4 hours post-CPB, (T5) 8 hours post-CPB, (T6) 12 hours post-CPB, (T7) 24 hours post-CPB, and (T8) 48 hours post-CPB were assayed for IL-6, IL-10, IL-19, IL-20, IL-22, and tumor necrotic factor-alpha (TNF-alpha). Transcripts of IL-19, IL-20, and IL-22 from monocytes were analyzed. In vitro, levels of IL-19, IL-20, and IL-22 production in monocytes incubated with IL-6 and TNF-alpha were determined.
RESULTS: The serum levels of IL-19 and IL-22 significantly increased at T3, peaked at T5, and remained increased at T8 (p<0.001). Induction of IL-19 and IL-22 was concomitant with the change in IL-10, IL-6, and TNF-alpha levels. Interleukin-19, IL-20, and IL-22 transcripts in monocytes from patients increased after CPB. In vitro experiments showed that IL-6 and TNF-alpha upregulated IL-19 protein expression in monocytes.
CONCLUSIONS: Serum IL-19 and IL-22 were induced in cardiac surgery with CPB and concomitant with induction of IL-6 and TNF-alpha. The IL-19 and these proinflammatory cytokines may interactively contribute to systemic inflammatory responses after CPB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731153     DOI: 10.1016/j.athoracsur.2006.01.092

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  The Association Between Sjögren Syndrome and Adverse Postoperative Outcomes: A Historical Cohort Study Using Administrative Health Data.

Authors:  Rovnat Babazade; Zhuo Sun; Brian D Hesler; Arjun Sharma; Natalya Makarova; Jarrod E Dalton; Alparslan Turan
Journal:  Anesth Analg       Date:  2015-11       Impact factor: 5.108

2.  Interleukin-19 acts as a negative autocrine regulator of activated microglia.

Authors:  Hiroshi Horiuchi; Bijay Parajuli; Yue Wang; Yasu-Taka Azuma; Tetsuya Mizuno; Hideyuki Takeuchi; Akio Suzumura
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 3.  IL-19 and Other IL-20 Family Member Cytokines in Vascular Inflammatory Diseases.

Authors:  Michael V Autieri
Journal:  Front Immunol       Date:  2018-04-06       Impact factor: 7.561

4.  Hypothermia Promotes Interleukin-22 Expression and Fine-Tunes Its Biological Activity.

Authors:  Evgeny Chichelnitskiy; Britta Himmelseher; Malte Bachmann; Josef Pfeilschifter; Heiko Mühl
Journal:  Front Immunol       Date:  2017-06-29       Impact factor: 7.561

5.  Recombinant Interleukin-19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms.

Authors:  Hiroki Tanaka; Baohui Xu; Haojun Xuan; Yingbin Ge; Yan Wang; Yankui Li; Wei Wang; Jia Guo; Sihai Zhao; Keith J Glover; Xiaoya Zheng; Shuai Liu; Kazunori Inuzuka; Naoki Fujimura; Yuko Furusho; Toru Ikezoe; Takahiro Shoji; Lixin Wang; Weiguo Fu; Jianhua Huang; Naoki Unno; Ronald L Dalman
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

6.  Anti-inflammatory effects of interleukin-19 in vascular disease.

Authors:  Ross N England; Michael V Autieri
Journal:  Int J Inflam       Date:  2012-07-15

7.  Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury.

Authors:  Yu-Hsiang Hsu; Hsing-Hui Li; Junne-Ming Sung; Wei-Ting Chen; Ya-Chin Hou; Ming-Shi Chang
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

Review 8.  Interleukin-19 in breast cancer.

Authors:  Ying-Yin Chen; Chien-Feng Li; Ching-Hua Yeh; Ming-Shi Chang; Chung-Hsi Hsing
Journal:  Clin Dev Immunol       Date:  2013-04-22

9.  Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progression.

Authors:  Chung-Hsi Hsing; Franky Antonius Kwok; Hung-Chi Cheng; Chien-Feng Li; Ming-Shi Chang
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

10.  Inflammatory milieu in contrast-induced nephropathy: a prospective single-center study.

Authors:  Ashraf O Oweis; Sameeha A Alshelleh; Ammar K Daoud; Mahmoud M Smadi; Karem H Alzoubi
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-08-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.